vs

Side-by-side financial comparison of Celsius Holdings, Inc. (CELH) and Healthpeak Properties (DOC). Click either name above to swap in a different company.

Celsius Holdings, Inc. is the larger business by last-quarter revenue ($721.6M vs $719.4M, roughly 1.0× Healthpeak Properties). Healthpeak Properties runs the higher net margin — 73.2% vs 3.4%, a 69.7% gap on every dollar of revenue. On growth, Celsius Holdings, Inc. posted the faster year-over-year revenue change (117.2% vs 3.1%). Healthpeak Properties produced more free cash flow last quarter ($357.0M vs $-130.0M). Over the past eight quarters, Celsius Holdings, Inc.'s revenue compounded faster (42.4% CAGR vs 8.9%).

Celsius Holdings, Inc. is an American company that produces a range of fitness and energy drinks under the brand name Celsius. The company's products are marketed as healthy, to which the CEO attributes the brand's success.

Healthpeak Properties, Inc. is an American real estate investment trust that invests in real estate related to the healthcare industry including senior housing, life science, and medical offices. It was organized in 2007 in Maryland and headquartered in Denver, Colorado with offices in Irvine, Nashville and San Francisco. As of December 31, 2019, the company owned interests in 617 properties.

CELH vs DOC — Head-to-Head

Bigger by revenue
CELH
CELH
1.0× larger
CELH
$721.6M
$719.4M
DOC
Growing faster (revenue YoY)
CELH
CELH
+114.2% gap
CELH
117.2%
3.1%
DOC
Higher net margin
DOC
DOC
69.7% more per $
DOC
73.2%
3.4%
CELH
More free cash flow
DOC
DOC
$487.0M more FCF
DOC
$357.0M
$-130.0M
CELH
Faster 2-yr revenue CAGR
CELH
CELH
Annualised
CELH
42.4%
8.9%
DOC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CELH
CELH
DOC
DOC
Revenue
$721.6M
$719.4M
Net Profit
$24.7M
$114.0M
Gross Margin
47.4%
Operating Margin
3.6%
17.4%
Net Margin
3.4%
73.2%
Revenue YoY
117.2%
3.1%
Net Profit YoY
231.1%
2406.4%
EPS (diluted)
$0.04
$0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CELH
CELH
DOC
DOC
Q4 25
$721.6M
$719.4M
Q3 25
$725.1M
$705.9M
Q2 25
$739.3M
$694.3M
Q1 25
$329.3M
$702.9M
Q4 24
$332.2M
$698.0M
Q3 24
$265.7M
$700.4M
Q2 24
$402.0M
$695.5M
Q1 24
$355.7M
$606.6M
Net Profit
CELH
CELH
DOC
DOC
Q4 25
$24.7M
$114.0M
Q3 25
$-61.0M
$-117.1M
Q2 25
$99.9M
$31.7M
Q1 25
$44.4M
$42.8M
Q4 24
$-18.9M
$4.5M
Q3 24
$6.4M
$85.9M
Q2 24
$79.8M
$146.0M
Q1 24
$77.8M
$6.7M
Gross Margin
CELH
CELH
DOC
DOC
Q4 25
47.4%
Q3 25
51.3%
58.6%
Q2 25
51.5%
60.2%
Q1 25
52.3%
61.1%
Q4 24
50.2%
60.3%
Q3 24
46.0%
60.0%
Q2 24
52.0%
60.6%
Q1 24
51.2%
59.8%
Operating Margin
CELH
CELH
DOC
DOC
Q4 25
3.6%
17.4%
Q3 25
-11.0%
9.2%
Q2 25
19.3%
5.7%
Q1 25
15.8%
7.7%
Q4 24
-5.6%
-2.2%
Q3 24
-1.2%
14.1%
Q2 24
23.4%
22.3%
Q1 24
23.4%
3.7%
Net Margin
CELH
CELH
DOC
DOC
Q4 25
3.4%
73.2%
Q3 25
-8.4%
-16.6%
Q2 25
13.5%
4.6%
Q1 25
13.5%
6.1%
Q4 24
-5.7%
0.7%
Q3 24
2.4%
12.3%
Q2 24
19.8%
21.0%
Q1 24
21.9%
1.1%
EPS (diluted)
CELH
CELH
DOC
DOC
Q4 25
$0.04
$0.16
Q3 25
$-0.27
$-0.17
Q2 25
$0.33
$0.05
Q1 25
$0.15
$0.06
Q4 24
$-0.10
$0.02
Q3 24
$0.00
$0.12
Q2 24
$0.28
$0.21
Q1 24
$0.27
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CELH
CELH
DOC
DOC
Cash + ST InvestmentsLiquidity on hand
$398.9M
$467.5M
Total DebtLower is stronger
$676.9M
$9.8B
Stockholders' EquityBook value
$1.2B
$7.5B
Total Assets
$5.1B
$20.3B
Debt / EquityLower = less leverage
0.57×
1.31×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CELH
CELH
DOC
DOC
Q4 25
$398.9M
$467.5M
Q3 25
$806.0M
$91.0M
Q2 25
$615.2M
$89.4M
Q1 25
$977.3M
$70.6M
Q4 24
$890.2M
$119.8M
Q3 24
$903.7M
$180.4M
Q2 24
$903.2M
$106.9M
Q1 24
$879.5M
$101.8M
Total Debt
CELH
CELH
DOC
DOC
Q4 25
$676.9M
$9.8B
Q3 25
$870.5M
$9.1B
Q2 25
$871.9M
$9.0B
Q1 25
$8.9B
Q4 24
$8.7B
Q3 24
$8.6B
Q2 24
$8.6B
Q1 24
$8.8B
Stockholders' Equity
CELH
CELH
DOC
DOC
Q4 25
$1.2B
$7.5B
Q3 25
$1.2B
$7.6B
Q2 25
$1.3B
$7.9B
Q1 25
$443.1M
$8.2B
Q4 24
$399.9M
$8.4B
Q3 24
$423.6M
$8.6B
Q2 24
$415.8M
$8.8B
Q1 24
$338.2M
$8.9B
Total Assets
CELH
CELH
DOC
DOC
Q4 25
$5.1B
$20.3B
Q3 25
$5.3B
$19.6B
Q2 25
$3.8B
$19.8B
Q1 25
$1.9B
$19.8B
Q4 24
$1.8B
$19.9B
Q3 24
$1.7B
$20.0B
Q2 24
$1.7B
$20.2B
Q1 24
$1.6B
$20.5B
Debt / Equity
CELH
CELH
DOC
DOC
Q4 25
0.57×
1.31×
Q3 25
0.72×
1.20×
Q2 25
0.69×
1.14×
Q1 25
1.08×
Q4 24
1.04×
Q3 24
1.00×
Q2 24
0.98×
Q1 24
0.99×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CELH
CELH
DOC
DOC
Operating Cash FlowLast quarter
$-119.4M
$1.3B
Free Cash FlowOCF − Capex
$-130.0M
$357.0M
FCF MarginFCF / Revenue
-18.0%
49.6%
Capex IntensityCapex / Revenue
1.5%
124.4%
Cash ConversionOCF / Net Profit
-4.83×
10.99×
TTM Free Cash FlowTrailing 4 quarters
$323.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CELH
CELH
DOC
DOC
Q4 25
$-119.4M
$1.3B
Q3 25
$331.8M
$315.0M
Q2 25
$43.7M
$363.5M
Q1 25
$103.4M
$279.4M
Q4 24
$75.7M
$1.1B
Q3 24
$12.9M
$318.2M
Q2 24
$39.6M
$316.2M
Q1 24
$134.6M
$152.6M
Free Cash Flow
CELH
CELH
DOC
DOC
Q4 25
$-130.0M
$357.0M
Q3 25
$321.5M
Q2 25
$35.5M
Q1 25
$96.4M
Q4 24
$70.3M
$333.7M
Q3 24
$8.7M
Q2 24
$30.4M
Q1 24
$130.1M
FCF Margin
CELH
CELH
DOC
DOC
Q4 25
-18.0%
49.6%
Q3 25
44.3%
Q2 25
4.8%
Q1 25
29.3%
Q4 24
21.2%
47.8%
Q3 24
3.3%
Q2 24
7.6%
Q1 24
36.6%
Capex Intensity
CELH
CELH
DOC
DOC
Q4 25
1.5%
124.4%
Q3 25
1.4%
Q2 25
1.1%
Q1 25
2.1%
Q4 24
1.6%
105.6%
Q3 24
1.6%
Q2 24
2.3%
Q1 24
1.3%
Cash Conversion
CELH
CELH
DOC
DOC
Q4 25
-4.83×
10.99×
Q3 25
Q2 25
0.44×
11.48×
Q1 25
2.33×
6.52×
Q4 24
235.43×
Q3 24
2.03×
3.71×
Q2 24
0.50×
2.17×
Q1 24
1.73×
22.85×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons